Trial intelligence / Profile preview

PK of Synera in Neonates and Infants

NCT00747669Phase 4Suspended

Sponsor
ZARS Pharmaceuticals
Start
Sep 2008
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tetracaine in procedural pain, sponsored by ZARS Pharmaceuticals. Started Sep 2008; status: suspended.

02

Drugs

tetracaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT00747669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00747669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call